Canopy(1) | $22,000,000 | (Jan 13, 2026)
Onsetto | $2,200,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
ZeroPhase
Germany
- Munich
- 23/12/2025
- Seed
- $6,800,000
ZeroPhase develops sovereign, software-defined connectivity systems that are resilient and available at scale. Our long-range, high-throughput data links are purpose-built for unmanned platforms and critical operations, ensuring reliable communication even in the most demanding environments.
We are a highly experienced, motivated, and ambitious team of engineers and innovators working with intensity and focus. What drives us is simple: to set a new standard in connectivity by combining performance, trust, and scalability - and to lay the foundation for the next generation of interconnected communication systems.
Our mission is clear - to make sovereign, software-defined communication systems that are not only state-of-the-art, but also accessible and dependable at scale.
- Industry Telecommunications
- Website https://www.zerophase.de/
- LinkedIn https://www.linkedin.com/company/zerophase-defense/
Related People
Florian PetitFounder
Germany -
Munich, Bavaria
CEO & Co-Founder of ZeroPhase
A passionate entrepreneur and tech enthusiast. Background in robotics with a focus on the control of robots in human-machine collaboration. Co-founded Blickfeld (Lidar perception). Co-founded SlingRFP (AI for Governmental Contracts). Now working on data links for drones at ZeroPhase.
When I’m not working, you can find me sailing on the local lakes of Bavaria or on a boulder wall.
Cytotheryx, Inc. | $60,000,000 | (Jan 13, 2026)
MEDIPOST, Inc. | $140,000,000 | (Jan 13, 2026)
TRYBE | $30,000,000 | (Jan 13, 2026)
Kinaset Therapeutics | $103,000,000 | (Jan 13, 2026)
Diagonal Therapeutics | $125,000,000 | (Jan 13, 2026)
VelaFi | $20,000,000 | (Jan 13, 2026)
encoord | $2,000,000 | (Jan 13, 2026)
Vibrant Therapeutics | $61,000,000 | (Jan 13, 2026)
Avenue Biosciences | $7,500,000 | (Jan 13, 2026)
Unusual | $3,600,000 | (Jan 13, 2026)